Home/ Supplements/ Niacin/ Focus Pep

Focus Pep

product on market Tablet or Pill Addrena Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 60% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

B-vitamins and choline support cognitive function and energy metabolism, while huperzine-A is associated with acetylcholinesterase inhibition. Research evidence for these individual components is generally moderate to strong. However, the specific Focus Pep Blend lacks detailed clinical data, contributing to the low overall evidence coverage.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Focus Pep
Open Full PDF View on NIH DSLD →
Details

Label Data

0.5 Tablet(s)
Serving Size
60
Servings
Other Combinations
Product Type
60%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

1.5 mg (9% DV)
Within RDA (0.1× RDA) 196 studies (A:5, B:63)
250 mcg (10417% DV)
104.2× RDA — above typical dose 139 studies (A:1, B:44)
50 mg (9% DV)
Within RDA (0.1× RDA) 38 studies (A:1, B:7)
Focus Pep Blend
1155.1 mg

Other Ingredients

Microcrystalline Cellulose Stearic Acid Dicalcium Phosphate Croscarmellose Sodium Magnesium Stearate Silicon Dioxide Pharmaceutical Glaze
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: To judge strength begin with half of a tablet. As a dietary supplement, take one pill daily. It is not recommended to take more than 2 tablets in one day. If you take 2 tablets at once please work up to this dose. Although some may find the product too strong others may find that it is not strong enough. If you have this experience please email info@addrena.com.

Warnings & Precautions

Warnings: Not intended for persons under the age of 18.

Do not use if pregnant or nursing. Consult a health care professional prior to consumption if you have any pre-existing medical conditions including but not limited to: hypertension, hypotension, anxiety, depression, seizure disorder, cardiac arrhythmia, stroke, heart, liver or thyroid disease; diabetes, psychiatric disease, asthma, difficulty urinating due to prostate enlargement, or if you are taking a MAO inhibitor or any prescription medication. Do not consume with any caffeine or stimulants including but not limited to: coffee, tea, soda, any dietary supplement containing caffeine or other products designed for weight loss or energy enhancement.

Reduce or discontinue use if sleeplessness, tremors, dizziness, nervousness, headaches or heart palpitations occur. Do not consume for at least two weeks prior to surgery. Improper use of this product will not improve results and is potentially hazardous to a person’s health. Do not take within 4 hours of bedtime. Drink at least ten 8 ounce glasses of water per day. Read warnings and only use as directed.

Keep out of reach of children.

Focus Pep can have stimulant side effects such as increased blood pressure, nausea, jitteriness, and a lack of sleep if taken after midday. Please promptly return this product if you bought this product in error of not knowing this. Only begin with half of a tablet when you start. If you have any issues please contact us immediately.

Formulation Notes

Dietary Supplement for adult men and women

Additional Information

Store in a cool, dry place.

Nootropic stimulant

Metadata

Product Details

UPC / SKU7 05332 98332 7
DSLD Entry Date2019-09-24
Product TypeOther Combinations
FormTablet or Pill
BrandAddrena
DSLD ID206740
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.